Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Series B Preferred Stock [Member]
Non-cash investing and financing transactions:
Series B preferred stock dividends accrued	$ 1,000	$ 1,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(1,629,398)	(1,370,706)
Depreciation	151,962	312,043
Accrued interest on deferred compensation and other	200,940	189,573
Stock-based compensation	233,094	31,043
Decrease in prepaid expenses	6,153	5,341
Increase in accounts payable and accrued expenses	27,351	225,779
Increase in deferred compensation and convertible notes	490,800	312,000
Net cash used in operating activities	(519,098)	$ (294,927)
Purchase of property and equipment	(4,251)
Net cash used by investing activities	(4,251)
Decrease in subscription receivable	$ 13,125	$ 30,000
Proceeds from sale of common stock		26,250
Proceeds from sale of units	$ 183,000	$ 67,500
Commissions on sale of units	(18,300)
Proceeds from exercise of warrants	184,689
Net cash provided by financing activities	362,514	$ 123,750
Net decrease in cash	(160,835)	(171,177)
Cash at beginning of period	339,286	186,148
Cash at end of period	$ 178,451	$ 14,971
Cash paid for interest
Issuance of common stock to satisfy deferred compensation	$ 171,717
Exercise of warrants for promissory note receivable for shares	$ 105,000